Calmare Therapeutics Incorporated

1375 Kings Highway East

Fairfield, CT 06824 33321

 

November 13, 2014

 

 

VIA EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

Re:

Calmare Therapeutics Incorporated

Registration Statement on Form S-1

Filed July 22, 2013

File No. 333- 190069

 

Ladies and Gentlemen:

 

Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), Calmare Therapeutics Incorporated (the “Company”) requests the withdrawal of the Company’s Registration Statement on Form S-1 originally filed on July 22, 2013, File No. 333-190069 (the “S-1 Registration Statement”). The Company has elected to withdraw the S-1 Registration Statement because it does not want to pursue an offering at this time. No sales of the Company’s common stock have been or will be made pursuant to the S-1 Registration Statement.

 

The Company requests that in accordance with Rule 457(p) under the Act, all fees paid to the Commission in connection with the filing of the above-captioned registration statement be credited for future use. If you have any questions regarding this request for withdrawal, please contact our legal counsel, Gregg E. Jaclin at (609) 275-0400.

 

Sincerely,

 

Calmare Therapeutics Incorporated

  

By:	/s/ Conrad Mir
Name:	Conrad Mir
Title:	Chief Executive Officer